首頁 > 市場調查報告書 > 醫療設備

美容整形

市場調查報告書

商品編碼

1427923

2024 年神經毒素全球市場報告

Neurotoxin Global Market Report 2024

出版日期: 2024年02月14日 | 出版商:

The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

神經毒素的市場規模預計在未來幾年將快速成長。預計到 2028 年將以 10.7% 的複合年成長率 (CAGR) 成長至 111.4 億美元。預測期內的預期成長可歸因於神經學應用的擴大、美容手術的持續需求、配方創新、消費者意識的提高以及美容旅遊的擴張。預測期內預計的顯著趨勢包括藥物輸送技術的進步、神經毒素開發和研究的合作、市場對神經毒素行業監管變化的反應以及對多學科治療計劃的緊張情緒。持久效果和患者滿意度。

神經毒素市場的預期成長預計將受到旨在改善外觀的整容手術的普及推動。整容手術包括各種醫療干預措施，其主要目的是改善或改變個人的外觀。這一趨勢受到社會、技術和文化因素的影響，再加上人們對整容手術的好處的認知不斷提高。神經毒素在這些過程中發揮著重要作用，它可以放鬆某些肌肉，從而減少皺紋和細紋的出現。例如，在2022年8月美國整形外科醫生協會關於整容手術的調查中，四分之三的美國整形外科醫生指出需求增加，30%的人表示整容手術的需求增加了一倍。他們的整容手術業務。為了改善外表而進行的整容手術的激增是推動神經毒素市場成長的關鍵驅動力。

隨著人口老化，神經毒素市場預計將擴大。術語「人口老化」是指以社會或人口中老年人比例增加為特徵的人口趨勢。隨著年齡的成長，我們經常轉向基於神經毒素的治療方法（例如肉毒桿菌）來解決與老齡化相關的美容問題，例如皺紋和臉部皺紋。這一人群正在尋求非侵入性的解決方案來改善他們的外表並實現更年輕和煥發活力的美學。據世界衛生組織 (WHO) 稱，全球 60 歲及以上人口正在迅速增加，預計到 2050 年將加倍，達到 21 億。因此，人口老化的加劇是推動神經毒素市場成長的關鍵因素。

全球神經毒素市場，依產品類型細分、實際及預測，2018-2023、2023-2028、2033
肉毒桿菌
Dysport
索敏
其他產品
全球神經毒素市場，按應用、實際和預測細分，2018-2023、2023-2028、2033
治療
美麗
全球神經毒素市場，按最終用戶細分，實際和預測，2018-2023、2023-2028、2033
醫院
專科診所
皮膚科診所
其他最終用戶

第 7 章區域與國家分析

全球神經毒素市場，按地區、績效和預測，2018-2023、2023-2028、2033
全球神經毒素市場，依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章德國市場

第18章法國市場

第19章義大利市場

第20章西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章加拿大市場

第26章南美洲市場

第27章巴西市場

第28章中東市場

第29章非洲市場

第30章競爭形勢及公司概況

神經毒素市場競爭形勢
神經毒素市場公司概況
- AbbVie Inc.
- Galderma Inc.
- Ipsen SA
- Daewoong Pharmaceutical Co. Ltd.
- Supernus Pharmaceuticals

第31章其他大型創新公司

Merz Pharma GmbH &Co KGaA
Hugel Inc.
Evolus Inc.
Medytox Inc.
Croma-Pharma GmbH
Revance Therapeutics Inc.
US WorldMeds
Gufic Biosciences Ltd.
Hironic Co. Ltd.
Allergan
List Biological Labs Inc.
Lanzhou Institute of Biological Products Co. Ltd.
Solstice Neurosciences
Sinclair Pharma
Vida Aesthetics

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章重大併購

第35章未來前景與可能性分析

第36章附錄

簡介目錄

Product Code: r13767

A neurotoxin is a substance specifically designed to be toxic to nerve cells (neurons) or the nervous system. These substances operate by inhibiting cellular processes within neurons.

The primary products classified as neurotoxins include well-known brands such as Botox, Dysport, Xeomin, and others. Botox, derived from the bacteria Clostridium botulinum, is a notable neurotoxin used for both cosmetic and medical purposes. It is employed to temporarily reduce the appearance of wrinkles and to treat certain muscular conditions. These neurotoxin products find applications in therapeutic and aesthetic contexts, with end-users ranging from hospitals and specialty clinics to dermatology clinics and other relevant healthcare facilities.

The neurotoxin market research report is one of a series of new reports from The Business Research Company that provides neurotoxin market statistics, including neurotoxin industry global market size, regional shares, competitors with a neurotoxin market share, detailed neurotoxin market segments, market trends and opportunities, and any further data you may need to thrive in the neurotoxin industry. This neurotoxin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The neurotoxin market size has grown rapidly in recent years. It will grow from $6.74 billion in 2023 to $7.43 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The expansion observed in the historical period can be attributed to several factors, including the increase in aesthetic procedures, the growing prevalence of therapeutic applications, advancements in the cosmetic industry, a rising aging population, and the increasing acceptance of non-surgical procedures.

The neurotoxin market size is expected to see rapid growth in the next few years. It will grow to $11.14 billion in 2028 at a compound annual growth rate (CAGR) of 10.7%. The anticipated growth in the forecast period can be attributed to the expanding applications in neurology, sustained demand for aesthetic procedures, innovations in formulations, increasing consumer awareness, and the expansion of cosmetic tourism. Notable trends expected in the forecast period include advancements in drug delivery techniques, collaborations for neurotoxin development and research, market responses to regulatory changes in the neurotoxin industry, the integration of neurotoxins in multimodal treatment plans, and a heightened focus on achieving long-lasting effects and ensuring patient satisfaction.

The anticipated growth in the neurotoxin market is expected to be propelled by the surge in cosmetic procedures aimed at improving appearance. Cosmetic procedures encompass a diverse range of medical interventions undertaken with the primary objective of enhancing or altering an individual's physical appearance. This trend is influenced by societal, technological, and cultural factors, coupled with increased awareness of the benefits associated with cosmetic procedures. Neurotoxins play a crucial role in these procedures by relaxing specific muscles, thereby reducing the appearance of wrinkles and fine lines. For instance, a cosmetic surgery survey by the American Society of Plastic Surgeons in August 2022 revealed a significant increase in demand for cosmetic procedures, with 3 out of 4 plastic surgeons in the USA noting a rise in demand, and 30% reporting a doubling of their cosmetic procedure businesses. This surge in cosmetic procedures to enhance appearance is a key driver fueling the growth of the neurotoxin market.

The growing aging population is expected to contribute to the expansion of the neurotoxin market. The term 'aging population' refers to a demographic trend characterized by an increasing proportion of elderly individuals within a society or population. As individuals age, they often turn to neurotoxin-based treatments, such as Botox, to address age-related cosmetic concerns such as wrinkles and facial lines. This demographic seeks non-invasive solutions to enhance their appearance and achieve a more youthful and rejuvenated aesthetic. According to the World Health Organization (WHO), the global population of people aged 60 years and older is growing rapidly, expected to double by 2050 and reach 2.1 billion. The growing aging population is thus a significant factor driving the growth of the neurotoxin market.

The innovation of facial aesthetic products is a notable trend gaining popularity in the neurotoxins market, with companies actively engaged in developing and introducing novel products to sustain their positions. One example is Evolus Inc., a US-based medical aesthetics company, which received approval from the Australian Therapeutic Goods Administration (TGA) in January 2023 for Nuceiva (prabotulinumtoxinA). Nuceiva is a neurotoxin specifically designed for aesthetic purposes, aiming to temporarily enhance the appearance of moderate glabellar lines in adult patients. By blocking nerve impulses to facial muscles, the product induces muscle relaxation, smoothing wrinkles resulting from facial expressions, squinting, and frowning.

Major companies operating in the neurotoxins market are emphasizing innovative products, including facial gel serums, with the goal of enhancing patient satisfaction. An example is the ready-to-use BoNT-A neuromodulator, a pre-formulated and prepared Botulinum Toxin Type A (BoNT-A) product. This product offers a convenient and standardized solution for healthcare practitioners in cosmetic or therapeutic applications. In September 2022, Entod Pharmaceuticals, an Indian-based pharmaceutical company, launched Vasuki, a facial gel serum based on synthetic tripeptide snake venom neurotoxin. The serum is formulated to gently relax muscle contractions under the skin, potentially reducing the appearance of wrinkles and fine lines.

In August 2021, Merz Pharma GmbH & Co. KGaA, a Germany-based pharmaceutical company in the neurotoxin market, entered into a strategic partnership agreement with Vensica Therapeutics Ltd., an Israel-based urology catheter designing and development company. The collaboration involves the delivery of botulinum neurotoxin A (Xeomin) to the bladder wall using Vensica's innovative ultrasound-assisted delivery catheter for urology applications. This strategic partnership reflects a commitment to advancing treatment options and delivery methods in the urology field through the combination of Merz's neurotoxin expertise and Vensica's innovative catheter technology.

Major companies operating in the neurotoxin market report are AbbVie Inc., Galderma Inc., Ipsen SA, Daewoong Pharmaceutical Co. Ltd., Supernus Pharmaceuticals, Merz Pharma GmbH & Co KGaA, Hugel Inc., Evolus Inc., Medytox Inc., Croma-Pharma GmbH, Revance Therapeutics Inc., US WorldMeds, Gufic Biosciences Ltd., Hironic Co. Ltd., Allergan, List Biological Laboratories, Lanzhou Institute of Biological Products Co. Ltd., Solstice Neurosciences, Sinclair Pharma, Vida Aesthetics, Aquavit Holdings LLC, PharmaResearch Products Co.Ltd., Entod Pharmaceuticals, Object Pharma Inc., Eisai Co. Ltd.

North America was the largest region in the neurotoxin market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurotoxin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the neurotoxin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neurotoxin market consists of sales of lead, ethanol (drinking alcohol), glutamate, nitric oxide, tetanus toxin, and tetrodotoxin. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neurotoxin Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neurotoxin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for neurotoxin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neurotoxin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Product Type: Botox; Dysport; Xeomin; Other Products
2) By Application: Therapeutic; Aesthetic
3) By End User: Hospitals; Specialty Clinics; Dermatology Clinics; Other End Users
Companies Mentioned: AbbVie Inc.; Galderma Inc.; Ipsen SA; Daewoong Pharmaceutical Co. Ltd.; Supernus Pharmaceuticals
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Neurotoxin Market Characteristics

3. Neurotoxin Market Trends And Strategies

4. Neurotoxin Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Neurotoxin Market Size and Growth

5.1. Global Neurotoxin Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Neurotoxin Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Neurotoxin Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Neurotoxin Market Segmentation

6.1. Global Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Botox
Dysport
Xeomin
Other Products
6.2. Global Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Therapeutic
Aesthetic
6.3. Global Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Specialty Clinics
Dermatology Clinics
Other End Users

7. Neurotoxin Market Regional And Country Analysis

7.1. Global Neurotoxin Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Neurotoxin Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Neurotoxin Market

8.1. Asia-Pacific Neurotoxin Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Neurotoxin Market

9.1. China Neurotoxin Market Overview
9.2. China Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Neurotoxin Market

10.1. India Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Neurotoxin Market

11.1. Japan Neurotoxin Market Overview
11.2. Japan Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Neurotoxin Market

12.1. Australia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Neurotoxin Market

13.1. Indonesia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Neurotoxin Market

14.1. South Korea Neurotoxin Market Overview
14.2. South Korea Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Neurotoxin Market

15.1. Western Europe Neurotoxin Market Overview
15.2. Western Europe Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Neurotoxin Market

16.1. UK Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Neurotoxin Market

17.1. Germany Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Neurotoxin Market

18.1. France Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Neurotoxin Market

19.1. Italy Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Neurotoxin Market

20.1. Spain Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Neurotoxin Market

21.1. Eastern Europe Neurotoxin Market Overview
21.2. Eastern Europe Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Neurotoxin Market

22.1. Russia Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Neurotoxin Market

23.1. North America Neurotoxin Market Overview
23.2. North America Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Neurotoxin Market

24.1. USA Neurotoxin Market Overview
24.2. USA Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Neurotoxin Market

25.1. Canada Neurotoxin Market Overview
25.2. Canada Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Neurotoxin Market

26.1. South America Neurotoxin Market Overview
26.2. South America Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Neurotoxin Market

27.1. Brazil Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Neurotoxin Market

28.1. Middle East Neurotoxin Market Overview
28.2. Middle East Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Neurotoxin Market

29.1. Africa Neurotoxin Market Overview
29.2. Africa Neurotoxin Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Neurotoxin Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Neurotoxin Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Neurotoxin Market Competitive Landscape And Company Profiles

30.1. Neurotoxin Market Competitive Landscape
30.2. Neurotoxin Market Company Profiles
- 30.2.1. AbbVie Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Galderma Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Ipsen SA
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Daewoong Pharmaceutical Co. Ltd.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Supernus Pharmaceuticals
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Neurotoxin Market Other Major And Innovative Companies

31.1. Merz Pharma GmbH & Co KGaA
31.2. Hugel Inc.
31.3. Evolus Inc.
31.4. Medytox Inc.
31.5. Croma-Pharma GmbH
31.6. Revance Therapeutics Inc.
31.7. US WorldMeds
31.8. Gufic Biosciences Ltd.
31.9. Hironic Co. Ltd.
31.10. Allergan
31.11. List Biological Labs Inc.
31.12. Lanzhou Institute of Biological Products Co. Ltd.
31.13. Solstice Neurosciences
31.14. Sinclair Pharma
31.15. Vida Aesthetics

32. Global Neurotoxin Market Competitive Benchmarking

33. Global Neurotoxin Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Neurotoxin Market

35. Neurotoxin Market Future Outlook and Potential Analysis

35.1 Neurotoxin Market In 2028 - Countries Offering Most New Opportunities
35.2 Neurotoxin Market In 2028 - Segments Offering Most New Opportunities
35.3 Neurotoxin Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies